Cucurbita pepo Linn.
1. Taxonomic, Nomenclature & Therapeutic Summary Table
| Botanical Attribute | Pharmacognostic & Therapeutic Specification |
|---|---|
| Family | Cucurbitaceae. |
| Habitat | Native to N. Mexico and eastern U.S.A. Now commonly cultivated in Northern India. |
| English | Pumpkin, Marrow. |
| Unani | Safed Kaddu, Kumhraa. |
| Siddha / Tamil | Suraikayi (Tamil). |
| Action | See C. maxima. |
| Key Application | Seeds—in irritated bladder condition, micturition problems of benign prostatic hyperplasia stages 1 and 2. (German Commission E, The British Herbal Pharmacopoeia.) In childhood enuresis noctruna. (Expanded Commission E.) |
| Taxonomic Cohort | Genus Cucurbita (3 documented species); Family Cucurbitaceae (32 documented species). |
2. Classical Nomenclature, Taxonomy & Biogeographical Context
Cucurbita pepo (taxonomically cited with authority Linn.) is an established medicinal plant species in Indian materia medica. It is classified under the botanical family Cucurbitaceae (primary family classification: Cucurbitaceae), placing it within a well-defined chemotaxonomic group of medicinal flora. Within botanical taxonomy, this taxon is cataloged directly under its primary accepted binomial without secondary botanical synonyms. Biogeographically, its documented habitat and ecological distribution span: Native to N. Mexico and eastern U.S.A. Now commonly cultivated in Northern India.
Across classical and vernacular Indian systems of medicine, Cucurbita pepo is recognized under distinct polyglot nomenclature: in English botanical and trade usage as Pumpkin, Marrow; in the Unani-Tibb materia medica (recorded in The National Formulary of Unani Medicine and CCRUM literature) as Safed Kaddu, Kumhraa; in the Siddha and Tamil medical tradition (compiled from the Formulary of Siddha Medicine and IMPCOPS Chennai) as Suraikayi (Tamil). Romanized Sanskrit and Ayurvedic spellings follow standard National Academy of Ayurveda (Rashtriya Ayurveda Vidyapeeth) transliteration conventions, using double vowels to preserve authentic classical pronunciation across regional medical traditions.
3. Therapeutic Actions, Phytochemistry & Pharmacological Profile
In therapeutic and clinical pharmacognosy, the primary recorded actions and clinical indications of Cucurbita pepo are: See C. maxima. These traditional and clinical attributes reflect the plant part-specific pharmacological profile documented across classical Indian treatises and modern herbal pharmacopoeias. Furthermore, international and national regulatory monographs highlight its validated key clinical application: Seeds—in irritated bladder condition, micturition problems of benign prostatic hyperplasia stages 1 and 2. (German Commission E, The British Herbal Pharmacopoeia.) In childhood enuresis noctruna. (Expanded Commission E.).
Experimental phytochemistry, active chemical constituents, and pharmacological screening studies reported for Cucurbita pepo establish the following evidence base: The roasted and fresh seeds yield 32.2 and 38.0% of fatty oil respectively. The oil filled capsules were administered to patients suffering from hypertrophy of the prostate. Results showed that the frequent urge to urinate decreased and the urine residues were minimized. The oil consists of the glycerides of linoleic 45, oleic 25, palmitic and stearic acids 30%. Sterols have been isolated.

Botanical Reference 1: Cucurbita pepo — Botanical specimen

Botanical Reference 2: Cucurbita pepo — Botanical specimen

Botanical Reference 3: Cucurbita pepo — Wikimedia Commons reference
4. Comparative Genus & Family Pharmacognosy
Taxonomically, the genus Cucurbita comprises 3 distinct medicinal species in Indian herbal literature. Closely allied congeneric species include: Cucurbita maxima (Action: Fruit pulp—sedative, emollient and refrigerant; used as poultice, applied to…); Cucurbita moschata (Action: Fruit—used in headache, bronchitis, asthma; as diuretic in genitourinary…). Comparing Cucurbita pepo alongside its congeners in genus Cucurbita highlights both shared secondary metabolite classes and species-specific organotropism across different ecological zones.
At the family level, Cucurbitaceae encompasses 32 documented medicinal species (1.76% of the 1,814-species flora). Other representative medicinal members of Cucurbitaceae include: Benincasa hispida (Kuushmaanda), Bryonopsis laciniosa (Lingini), Citrullus colocynthis (Indravaaruni), Citrullus vulgaris (Kalinga), Coccinia indica (Bimbi). In comparative pharmacognosy, evaluating species within the same botanical family aids quality control, authentication of crude drugs, and identification of chemotaxonomic markers.

Figure 1: Quantitative documentation profile across all 32 medicinal species of family Cucurbitaceae.
5. Pharmacopoeial Standards, Posology & Reference Framework
In clinical and traditional dispensing, preparation and administration of Cucurbita pepo follow the plant-part modalities specified under its therapeutic action (See C. maxima), guided by the standard posological principles of The Ayurvedic Pharmacopoeia of India (Vols. I–IV) and CCRAS formularies. Classical and modern pharmacognostic synchronization for Cucurbita pepo integrates standards from The Ayurvedic Pharmacopoeia of India, The National Formulary of Unani Medicine, Formulary of Siddha Medicine, The Wealth of India (CSIR), Compendium of Indian Medicinal Plants (CDRI), Dictionary of Indian Medicinal Plants (CIMAP), German Commission E, ESCOP, WHO monographs, British Herbal Pharmacopoeia, and Natural Medicines Comprehensive Database.